Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-03-27 Purchase | 2024-03-27 8:47 pm | Mirum Pharmaceuticals Inc. | MIRM | BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | 2,000 | $24.8 | $49,600 | 14,000 (Direct) | View |
2024-03-25 Sale | 2024-03-25 5:41 pm | Mirum Pharmaceuticals Inc. | MIRM | Radovich Peter PRESIDENT AND COO | 4,303 | $25.8 | $111,017 | 29,013 (Direct) | View |
2023-01-09 Sale | 2024-03-18 5:46 pm | Mirum Pharmaceuticals Inc. | MIRM | Radovich Peter PRESIDENT AND COO | 1,379 | $20.62 | $28,438 | 33,316 (Direct) | View |
2023-01-09 Sale | 2024-03-18 5:44 pm | Mirum Pharmaceuticals Inc. | MIRM | Vig Pamela CHIEF SCIENTIFIC OFFICER | 1,379 | $20.62 | $28,438 | 102,312 (Indirect Direct) | View |
2019-09-10 Purchase | 2024-03-18 5:40 pm | Mirum Pharmaceuticals Inc. | MIRM | Longpre Lara CHIEF DEVELOPMENT OFFICER | 965 | $10.64 | $10,268 | 104,369 (Direct) | View |
2023-01-09 Sale | 2024-03-18 5:40 pm | Mirum Pharmaceuticals Inc. | MIRM | Longpre Lara CHIEF DEVELOPMENT OFFICER | 1,003 | $20.62 | $20,684 | 104,369 (Direct) | View |
2023-01-09 Sale | 2024-03-18 5:37 pm | Mirum Pharmaceuticals Inc. | MIRM | Peetz Christopher CHIEF EXECUTIVE OFFICER | 5,159 | $20.62 | $106,390 | 300,523 (Indirect Direct) | View |
2024-03-18 Purchase | 2024-03-18 5:34 pm | Mirum Pharmaceuticals Inc. | MIRM | BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | 2,000 | $25.8 | $51,600 | 12,000 (Direct) | View |
2024-02-02 Sale | 2024-02-05 9:12 pm | Mirum Pharmaceuticals Inc. | MIRM | Vig Pamela CHIEF SCIENTIFIC OFFICER | 1,214 | $26.19 | $31,797 | 103,691 (Indirect Direct) | View |
2024-02-02 Sale | 2024-02-05 9:10 pm | Mirum Pharmaceuticals Inc. | MIRM | Longpre Lara CHIEF DEVELOPMENT OFFICER | 847 | $26.19 | $22,184 | 104,407 (Direct) | View |
2024-02-02 Sale | 2024-02-05 9:05 pm | Mirum Pharmaceuticals Inc. | MIRM | Radovich Peter PRESIDENT AND COO | 1,790 | $26.19 | $46,883 | 34,695 (Direct) | View |
2024-02-02 Sale | 2024-02-05 9:04 pm | Mirum Pharmaceuticals Inc. | MIRM | Peetz Christopher CHIEF EXECUTIVE OFFICER | 6,013 | $26.19 | $157,491 | 305,682 (Indirect Direct) | View |
2024-02-02 Sale | 2024-02-02 9:28 pm | Mirum Pharmaceuticals Inc. | MIRM | Howe Jolanda SVP, GLOBAL CONTROLLER | 735 | $26.19 | $19,251 | 5,302 (Direct) | View |
2024-01-08 Sale | 2024-01-09 8:28 pm | Mirum Pharmaceuticals Inc. | MIRM | Radovich Peter CHIEF OPERATING OFFICER | 1,408 | $28.03 | $39,473 | 36,485 (Direct) | View |
2024-01-08 Sale | 2024-01-09 8:25 pm | Mirum Pharmaceuticals Inc. | MIRM | Longpre Lara CHIEF DEVELOPMENT OFFICER | 1,019 | $28.04 | $28,568 | 105,254 (Direct) | View |
2024-01-08 Sale | 2024-01-09 8:21 pm | Mirum Pharmaceuticals Inc. | MIRM | Vig Pamela HEAD OF RESEARCH & DEVELOPMENT | 1,408 | $28.03 | $39,472 | 104,905 (Indirect Direct) | View |
2024-01-08 Sale | 2024-01-09 8:12 pm | Mirum Pharmaceuticals Inc. | MIRM | Peetz Christopher PRESIDENT AND CEO | 5,209 | $28.03 | $146,033 | 311,695 (Indirect Direct) | View |
2024-01-08 Sale | 2024-01-09 8:09 pm | Mirum Pharmaceuticals Inc. | MIRM | Howe Jolanda SVP, GLOBAL CONTROLLER | 528 | $28.04 | $14,803 | 1,972 (Direct) | View |
2023-12-05 Sale | 2023-12-06 5:16 pm | Mirum Pharmaceuticals Inc. | MIRM | Howe Jolanda SVP, Global Controller | 2,500 | $32.4 | $81,000 | 55,400 (Direct) | View |
2023-11-09 Purchase | 2023-11-14 4:35 pm | Mirum Pharmaceuticals Inc. | MIRM | Heron Patrick J Director | 2,910 | $28.3 | $82,353 | 3,728,875 (Indirect) | View |
2023-09-13 Purchase | 2023-09-15 4:56 pm | Mirum Pharmaceuticals Inc. | MIRM | Heron Patrick J Director | 2,625 | $31.02 | $81,425 | 3,725,965 (Indirect) | View |
2023-09-13 Sale | 2023-09-14 7:33 pm | Mirum Pharmaceuticals Inc. | MIRM | GREY MICHAEL G Director | 14,608 | $32 | $467,456 | 1,059,516 (Indirect Direct) | View |
2023-09-11 Purchase | 2023-09-13 4:39 pm | Mirum Pharmaceuticals Inc. | MIRM | Heron Patrick J Director | 8,437 | $30.44 | $256,791 | 3,723,340 (Indirect) | View |
2023-09-11 Purchase | 2023-09-12 6:23 pm | Mirum Pharmaceuticals Inc. | MIRM | BJERKHOLT ERIC Chief Financial Officer | 10,000 | $29.65 | $296,492 | 175,000 (Direct) | View |
2023-08-31 Purchase | 2023-09-05 12:51 pm | Mirum Pharmaceuticals Inc. | MIRM | Heron Patrick J Director 10% Owner | 147,991 | $26.25 | $3,884,764 | 3,714,903 (Indirect) | View |
2023-08-25 Sale | 2023-08-28 4:30 pm | Mirum Pharmaceuticals Inc. | MIRM | Howe Jolanda SVP, Global Controller | 3,459 | $26.23 | $90,743 | 0 (Direct) | View |
2023-07-03 Sale | 2023-07-05 7:47 pm | Mirum Pharmaceuticals Inc. | MIRM | Radovich Peter Chief Operating Officer | 1,425 | $25.65 | $36,546 | 37,675 (Direct) | View |
2023-07-03 Sale | 2023-07-05 7:37 pm | Mirum Pharmaceuticals Inc. | MIRM | Longpre Lara Chief Development Officer | 1,004 | $25.65 | $25,749 | 105,839 (Direct) | View |
2023-07-03 Sale | 2023-07-05 7:35 pm | Mirum Pharmaceuticals Inc. | MIRM | Vig Pamela Head of Research & Development | 1,425 | $25.65 | $36,546 | 105,786 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-01-31 Exercise | 2024-02-02 9:28 pm | N/A N/A | Mirum Pharmaceuticals Inc. | MIRM | Howe Jolanda SVP, GLOBAL CONTROLLER | 1,772 | $0 | 5,302 (Direct) | View |
2024-01-23 Option Award | 2024-01-25 7:10 pm | N/A 2034-01-22 | Mirum Pharmaceuticals Inc. | MIRM | Vig Pamela CHIEF SCIENTIFIC OFFICER | 40,000 | $0 | 40,000 (Direct) | View |
2024-01-23 Option Award | 2024-01-25 7:10 pm | N/A 2034-01-22 | Mirum Pharmaceuticals Inc. | MIRM | Longpre Lara CHIEF DEVELOPMENT OFFICER | 40,000 | $0 | 40,000 (Direct) | View |
2024-01-23 Option Award | 2024-01-25 7:10 pm | N/A 2034-01-22 | Mirum Pharmaceuticals Inc. | MIRM | BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | 40,000 | $0 | 40,000 (Direct) | View |
2024-01-23 Option Award | 2024-01-25 7:10 pm | N/A 2034-01-22 | Mirum Pharmaceuticals Inc. | MIRM | Howe Jolanda SVP, GLOBAL CONTROLLER | 22,500 | $0 | 22,500 (Direct) | View |
2024-01-23 Option Award | 2024-01-25 7:10 pm | N/A 2034-01-22 | Mirum Pharmaceuticals Inc. | MIRM | Radovich Peter PRESIDENT AND COO | 87,250 | $0 | 87,250 (Direct) | View |
2024-01-23 Option Award | 2024-01-25 7:10 pm | N/A 2034-01-22 | Mirum Pharmaceuticals Inc. | MIRM | Peetz Christopher CHIEF EXECUTIVE OFFICER | 187,500 | $0 | 187,500 (Direct) | View |
2024-01-16 Option Award | 2024-01-18 7:42 pm | N/A 2034-01-15 | Mirum Pharmaceuticals Inc. | MIRM | Quan Joanne CHIEF MEDICAL OFFICER | 112,500 | $0 | 112,500 (Direct) | View |
2024-01-06 Exercise | 2024-01-09 8:09 pm | N/A N/A | Mirum Pharmaceuticals Inc. | MIRM | Howe Jolanda SVP, GLOBAL CONTROLLER | 1,250 | $0 | 1,972 (Direct) | View |
2023-12-05 Exercise | 2023-12-06 5:16 pm | N/A 2029-03-11 | Mirum Pharmaceuticals Inc. | MIRM | Howe Jolanda SVP, Global Controller | 2,500 | $0 | 55,400 (Direct) | View |
2023-12-05 Exercise | 2023-12-06 5:16 pm | N/A N/A | Mirum Pharmaceuticals Inc. | MIRM | Howe Jolanda SVP, Global Controller | 2,500 | $2.94 | 55,400 (Direct) | View |
2023-11-10 Option Award | 2023-11-15 8:14 pm | N/A N/A | Mirum Pharmaceuticals Inc. | MIRM | Vig Pamela Head of Research & Development | 527 | $22.29 | 106,313 (Direct) | View |
2023-11-10 Option Award | 2023-11-15 8:13 pm | N/A N/A | Mirum Pharmaceuticals Inc. | MIRM | Longpre Lara Chief Development Officer | 434 | $22.29 | 106,273 (Direct) | View |
2023-11-10 Option Award | 2023-11-15 8:11 pm | N/A N/A | Mirum Pharmaceuticals Inc. | MIRM | Radovich Peter Chief Operating Officer | 218 | $22.29 | 37,893 (Direct) | View |
2023-09-13 Exercise | 2023-09-14 7:33 pm | N/A 2029-03-11 | Mirum Pharmaceuticals Inc. | MIRM | GREY MICHAEL G Director | 14,608 | $0 | 1,059,516 (Direct) | View |
2023-09-13 Exercise | 2023-09-14 7:33 pm | N/A N/A | Mirum Pharmaceuticals Inc. | MIRM | GREY MICHAEL G Director | 14,608 | $2.936 | 1,059,516 (Direct) | View |
2023-09-11 Option Award | 2023-09-12 6:23 pm | N/A 2033-09-10 | Mirum Pharmaceuticals Inc. | MIRM | BJERKHOLT ERIC Chief Financial Officer | 165,000 | $0 | 175,000 (Direct) | View |